(2S,5S)-5-[(S)-2-(Acetyl-methyl-amino)-3-(S)-methyl-pentanoylamino]-4-oxo-1,2,4,5,6,7-hexahydro-azepino[3,2,1-hi]indole-2-carboxylic acid (3-hydroxy-isoxazol-5-ylmethyl)-amide

ID: ALA305418

PubChem CID: 44310108

Max Phase: Preclinical

Molecular Formula: C26H33N5O6

Molecular Weight: 511.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@@H](C(=O)N[C@H]1CCc2cccc3c2N(C1=O)[C@H](C(=O)NCc1cc(O)no1)C3)N(C)C(C)=O

Standard InChI:  InChI=1S/C26H33N5O6/c1-5-14(2)22(30(4)15(3)32)25(35)28-19-10-9-16-7-6-8-17-11-20(31(23(16)17)26(19)36)24(34)27-13-18-12-21(33)29-37-18/h6-8,12,14,19-20,22H,5,9-11,13H2,1-4H3,(H,27,34)(H,28,35)(H,29,33)/t14-,19-,20-,22-/m0/s1

Standard InChI Key:  DEDSPRJAOZIWFP-YXXMBDFVSA-N

Molfile:  

     RDKit          2D

 37 40  0  0  1  0  0  0  0  0999 V2000
    7.3875   -4.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0792   -4.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6417   -4.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4917   -4.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5875   -3.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4042   -3.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8792   -5.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8125   -6.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2417   -4.4792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7500   -3.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9042   -3.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1125   -5.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0792   -4.3042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8292   -4.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2542   -5.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6542   -5.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4125   -6.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4167   -4.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8375   -5.6750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4042   -3.3292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292   -5.2000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0875   -2.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4042   -5.7167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7417   -3.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -5.6167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5292   -5.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2750   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9250   -5.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2792   -4.8167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7250   -2.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9875   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6667   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292   -1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4042   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2625   -5.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6667   -5.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3542   -6.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  9  1  0
  5  1  1  0
  6  5  1  0
  7 15  2  0
  8 17  1  0
 11  9  1  1
 10  2  1  0
 11  3  1  0
  2 12  1  1
 14 13  1  6
 14  4  1  0
 15 26  1  0
 16  7  1  0
 17 15  1  0
 18 13  1  0
 19 12  1  0
 20  4  2  0
 21  3  2  0
 22  5  2  0
 23 12  2  0
 24 11  1  0
 25 18  2  0
 26 19  1  0
 27 22  1  0
 28 14  1  0
 29 16  1  0
 30  6  2  0
 31 13  1  0
 32 18  1  0
 33 34  2  0
 34 22  1  0
 35 28  1  0
 28 36  1  1
 37 35  1  0
  6 10  1  0
 27 24  1  0
 30 33  1  0
  8 16  2  0
M  END

Associated Targets(Human)

GZMB Tchem Granzyme B (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 511.58Molecular Weight (Monoisotopic): 511.2431AlogP: 1.28#Rotatable Bonds: 8
Polar Surface Area: 145.08Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.91CX Basic pKa: CX LogP: 1.13CX LogD: -0.82
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.48Np Likeness Score: -0.33

References

1. Willoughby CA, Bull HG, Garcia-Calvo M, Jiang J, Chapman KT, Thornberry NA..  (2002)  Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.,  12  (16): [PMID:12127536] [10.1016/s0960-894x(02)00363-3]

Source